Compounds > melagatran
Page last updated: 2024-09-05

melagatran and eptifibatide

melagatran has been researched along with eptifibatide in 2 studies

Compound Research Comparison

Studies
(melagatran)		Trials
(melagatran)		Recent Studies (post-2010)
(melagatran)		Studies
(eptifibatide)		Trials
(eptifibatide)		Recent Studies (post-2010) (eptifibatide)
1853219907220212

Protein Interaction Comparison

ProteinTaxonomymelagatran (IC50)eptifibatide (IC50)
Integrin beta-3Homo sapiens (human)0.226
Integrin alpha-IIbHomo sapiens (human)0.226

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Lombardo, F; Obach, RS; Waters, NJ1
Cvirn, G; Gallistl, S; Koestenberger, M; Leschnik, B; Muntean, W; Rehak, T; Roschitz, B1

Other Studies

2 other study(ies) available for melagatran and eptifibatide

ArticleYear
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
    Drug metabolism and disposition: the biological fate of chemicals, 2008, Volume: 36, Issue:7

    Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding

2008
Combined effects of melagatran and eptifibatide on platelet aggregation inhibition but not thrombin generation inhibition.
    Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis, 2004, Volume: 15, Issue:2

    Topics: Azetidines; Benzylamines; Dose-Response Relationship, Drug; Drug Synergism; Eptifibatide; Factor Xa; Glycine; Humans; Peptide Fragments; Peptides; Platelet Aggregation; Platelet Aggregation Inhibitors; Prothrombin; Thrombin; Thromboplastin

2004